VICKS SINEX DECONGESTANT NASAL SPRAY 0.05% .05 %
OXYMETAZOLINE HYDROCHLORIDE : .05 % · DIN 02008149 · PROCTER & GAMBLE INC
Health Canada status: CANCELLED POST MARKET
What is VICKS SINEX DECONGESTANT NASAL SPRAY 0.05%?
VICKS SINEX DECONGESTANT NASAL SPRAY 0.05% .05 % contains OXYMETAZOLINE HYDROCHLORIDE : .05 %. It is listed in the Health Canada Drug Product Database under DIN 02008149, held by PROCTER & GAMBLE INC, supplied as LIQUID for NASAL administration. Health Canada currently lists it as cancelled post market, status dated 12-Apr-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is VICKS SINEX DECONGESTANT NASAL SPRAY 0.05% called?
The same molecule, OXYMETAZOLINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| ClariSpray Menthol | Latin | Saudi Arabia |
| ClariSpray Original | Latin | Saudi Arabia |
| Drixine | Latin | Australia |
| ILIADIN | Latin | Saudi Arabia |
| ILIADIN ADULT | Latin | Saudi Arabia |
| ILIADIN INFANT | Latin | Saudi Arabia |
| Logicin Rapid Relief | Latin | Australia |
| Nazene Z Nasal Spray | Latin | South Africa |
| Pharmacy Action Nasal Decongestant | Latin | Australia |
| Trust Decongestant Nasal Spray | Latin | Australia |
| VICKS SINEX NASAL SPRAY. | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02008149 |
|---|---|
| Brand name | VICKS SINEX DECONGESTANT NASAL SPRAY 0.05% |
| Generic / active ingredient | OXYMETAZOLINE HYDROCHLORIDE : .05 % |
| Manufacturer | PROCTER & GAMBLE INC |
| Strength | .05 % |
| Dosage form | LIQUID |
| Route of administration | NASAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01AA05 OXYMETAZOLINE |
| AHFS class | 52:32.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 12-Apr-2021 |
| Original market date | 1985-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02008149 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2008149 |
| Brand name | VICKS SINEX DECONGESTANT NASAL SPRAY 0.05% |
| Active ingredient / INN | OXYMETAZOLINE HYDROCHLORIDE : .05 % |
| ATC code | R01AA05 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R01 |
| AHFS class | 52:32.00 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | PROCTER & GAMBLE INC |
Which pack is which?
| Strength on the label | .05 % |
|---|---|
| Dosage form | LIQUID |
| Route | NASAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code R01AA05 OXYMETAZOLINE. 13 of 42 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CLARITIN ALLERGY DECONGESTANT | 0.05 % | SOLUTION | BAYER INC | MARKETED | DIN 02243690 |
| DRIXORAL DECONGESTANT NASAL SPRAY | 0.05 % | SOLUTION | BAYER INC | MARKETED | DIN 00740861 |
| DRIXORAL NASAL CONGESTION | 0.05 % | SPRAY | BAYER INC | MARKETED | DIN 02380129 |
| DRIXORAL NO DRIP COOLING MENTHOL | 0.05 % | SPRAY | BAYER INC | MARKETED | DIN 02245580 |
| DRIXORAL NO DRIP EXTRA MOISTURIZING | 0.05 % | SPRAY | BAYER INC | MARKETED | DIN 02245575 |
| DRIXORAL NO DRIP NASAL CONGESTION | 0.05 % | SPRAY | BAYER INC | MARKETED | DIN 02498294 |
| DRIXORAL NO DRIP NASAL CONGESTION WITH MENTHOL | 0.05 % | SPRAY | BAYER INC | MARKETED | DIN 02498308 |
| DRIXORAL NO DRIP ORIGINAL UNSCENTED | 0.05 % | SPRAY | BAYER INC | MARKETED | DIN 02245578 |
| EXTRA MOISTURIZING NASAL SPRAY | 0.05 % | SPRAY, METERED DOSE | JUNO OTC INC | MARKETED | DIN 02460572 |
| LONG LASTING DECONGESTANT NASAL SPRAY | 0.05 % | SPRAY | CRLS | MARKETED | DIN 02454351 |
Who else supplies OXYMETAZOLINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OXYMETAZOLINE appears in 56 registered pack listings across 5 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does OXYMETAZOLINE cost around the world?
OXYMETAZOLINE is listed on 3 national price registers Nexara tracks, across 18 pack listings published on 3 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Saudi Arabia | public | 8 | 8 | 01 Sep 2026 |
| South Africa | single exit price | 5 | 6 | 01 Sep 2026 |
| Australia | ex-manufacturer | 4 | 4 | 08 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.